V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20217588 | 20168747 | 1.77 | 66.5 | Palliative (P) | 2019-08-21 | 2019-08-22 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101310422 |
| 20217593 | 20168748 | 1.55 | 56.25 | Adjuvant (A) | 2021-02-22 | 2021-02-24 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100792392 |
| 20217594 | 20168749 | 1.76 | 58 | Disease modification (D) | 2018-06-23 | 2018-06-27 | Sorafenib | N | N | SORAFENIB | 100818713 |
| 20217606 | 20168750 | 1.75 | 100.5 | 03 | 2019-05-01 | 2019-05-02 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 101774989 |
| 20217611 | 20168751 | 1.85 | 76.4 | Curative (C) | 2018-02-08 | 2018-02-10 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 01 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101813711 |
| 20217614 | 20168752 | 1.75 | 40.6 | null | 2018-04-15 | 2018-04-15 | EOX | 02 | N | EOX | 101795127 |
| 20217617 | 20168753 | 1.62 | 53 | Curative (C) | 2016-09-25 | 2016-11-09 | EOX | 2 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100543322 |
| 20217625 | 20168754 | 1.63 | 72.7 | Palliative (P) | 2017-05-26 | 2017-08-09 | EOX | N | N | TRIAL | 100644966 |
| 20217626 | 20168755 | 1.75 | 68.1 | Palliative (P) | 2019-07-30 | 2019-08-13 | EOX | Y | N | CETUXIMAB + IRINOTECAN + MDG | 100349850 |
| 20217630 | 20168756 | 1.7 | 58.8 | Neo-adjuvant (N) | 2016-05-20 | 2016-05-20 | Capecitabine 35days + RT | 02 | Y | CAPECITABINE + RT | 101483077 |
| 20217635 | 20168757 | 1.76 | 60.3 | Palliative (P) | 2019-08-20 | 2019-08-20 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100564512 |
| 20217650 | 20168758 | 0 | 80.8 | Neo-adjuvant (N) | 2019-11-09 | 2019-12-14 | Sorafenib | 02 | N | SORAFENIB | 101748297 |
| 20217654 | 20168759 | 1.75 | 108 | Palliative (P) | 2017-02-12 | 2018-05-01 | Capecitabine 35days + RT | N | N | CAPECITABINE + RT | 100074409 |
| 20217655 | 20168760 | 1.79 | 77.5 | Palliative (P) | 2021-08-16 | 2021-08-16 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101732104 |
| 20217656 | 20168761 | 1.67 | 82.1 | Neo-adjuvant (N) | 2018-03-30 | 2018-05-03 | EOX | Y | Y | CETUXIMAB + IRINOTECAN + MDG | 100091496 |
| 20217665 | 20168762 | null | null | Palliative (P) | 2016-06-08 | 2016-06-24 | EOX | 02 | N | EOX | 100561873 |
| 20217690 | 20168763 | 1.83 | 63 | 03 | 2019-02-11 | 2019-03-21 | EOX | 02 | Y | CAPECITABINE + RT | 100620826 |
| 20217702 | 20168764 | 1.85 | 102.2 | null | 2017-11-23 | 2017-11-24 | Cetuximab + FOLFIRI cycle1 | N | null | CETUXIMAB + IRINOTECAN + MDG | 100297476 |
| 20217718 | 20168765 | 1.61 | 60 | Palliative (P) | 2019-11-07 | 2019-12-05 | EOX | 02 | null | EOX | 101468388 |
| 20217724 | 20168766 | 1.83 | 59.2 | null | 2018-12-05 | 2018-12-05 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100290850 |
| 20217752 | 20168767 | 1.66 | 75.1 | Adjuvant (A) | 2018-03-02 | 2018-03-03 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101566733 |
| 20217761 | 20168768 | 1.69 | 72 | Neo-adjuvant (N) | 2020-01-25 | 2020-02-06 | Sorafenib | 02 | Y | SORAFENIB | 101286693 |
| 20217775 | 20168769 | 1.84 | 88.7 | Curative (C) | 2018-10-30 | 2018-11-05 | EOX | 02 | N | SORAFENIB | 101211440 |
| 20217781 | 20168770 | 1.79 | 60.8 | null | 2019-05-19 | 2019-06-02 | IRINOTECAN + MDG + PANITUMUMAB | 99 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100499828 |
| 20217795 | 20168771 | 1.72 | 78.4 | Palliative (P) | 2018-02-27 | 2018-02-27 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100933505 |
| 20217816 | 20168772 | 1.54 | 99.5 | Curative (C) | 2021-03-19 | 2021-04-16 | Trial Unspecified | 2 | N | OXALIPLATIN + RALTITREXED | 100592450 |
| 20217817 | 20168773 | 1.56 | 60 | Palliative (P) | 2017-01-07 | 2017-02-11 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100027642 |
| 20217818 | 20168774 | 0 | 58.8 | Palliative (P) | 2017-01-10 | 2017-02-02 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100290771 |
| 20217828 | 20168775 | 1.7 | 54.3 | Neo-adjuvant (N) | 2019-10-10 | 2019-10-11 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101285687 |
| 20217835 | 20168776 | 1.72 | 102 | Palliative (P) | 2021-08-06 | 2021-08-10 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101687137 |
| 20217849 | 20168777 | 0 | 82.7 | Palliative (P) | 2021-05-01 | 2021-10-27 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100014071 |
| 20217859 | 20168778 | 1.76 | 109.8 | Palliative (P) | 2016-01-04 | 2016-04-29 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101433099 |
| 20217861 | 20168779 | 1.63 | 80 | Palliative (P) | 2017-02-28 | 2017-03-07 | EOX | 02 | N | CAPECITABINE + RT | 101601494 |
| 20217869 | 20168780 | 1.64 | 47 | Palliative (P) | 2020-01-28 | 2020-02-08 | Capecitabine 5days + RT | 02 | N | CAPECITABINE + RT | 100204204 |
| 20217887 | 20168781 | 1.7 | 76 | Palliative (P) | 2016-06-03 | 2016-06-03 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100091340 |
| 20217893 | 20168782 | 1.6 | 63.1 | Palliative (P) | 2018-03-03 | 2019-01-28 | Sorafenib | 02 | N | SORAFENIB | 101581434 |
| 20217899 | 20168783 | null | 66 | Palliative (P) | 2019-05-24 | 2019-07-03 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | null | CETUXIMAB + IRINOTECAN + MDG | 100083245 |
| 20217922 | 20168784 | 1.84 | 47.6 | Adjuvant (A) | 2018-06-27 | 2018-07-18 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100148877 |
| 20217924 | 20168785 | 1.72 | 66.8 | Palliative (P) | 2018-03-28 | 2018-04-11 | Sorafenib | N | N | SORAFENIB | 100222873 |
| 20217934 | 20168786 | 1.7 | null | Disease modification (D) | 2015-08-08 | 2016-03-03 | Trial Unspecified | N | Y | TRIAL | 101174738 |
| 20217948 | 20168787 | 1.75 | 102.2 | Palliative (P) | 2019-02-03 | 2019-02-12 | EOX | 02 | null | CAPECITABINE + RT | 101581186 |
| 20217952 | 20168788 | 1.7 | 58 | Palliative (P) | 2019-01-18 | 2019-01-27 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100406789 |
| 20217953 | 20168789 | 1.6 | 61.3 | Palliative (P) | 2019-03-04 | 2019-10-05 | EOX | N | Y | TRIAL | 100016105 |
| 20217965 | 20168790 | 1.76 | 65 | Palliative (P) | 2019-08-28 | 2019-10-09 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100148009 |
| 20217978 | 20168791 | 1.66 | 56.6 | Neo-adjuvant (N) | 2018-04-09 | 2018-05-07 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101677082 |
| 20217985 | 20168792 | 1.74 | 68.4 | null | 2016-03-17 | 2016-04-03 | EOX | N | null | TRIAL | 101670572 |
| 20217987 | 20168793 | null | 65 | Palliative (P) | 2019-08-18 | 2019-08-22 | EOX | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101755936 |
| 20217989 | 20168794 | 1.76 | 76.7 | Curative (C) | 2017-07-11 | 2017-07-11 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 2 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101038346 |
| 20217992 | 20168795 | 1.83 | 80.75 | Palliative (P) | 2019-03-27 | 2019-04-11 | EOX | 01 | N | TRIAL | 101860127 |
| 20217993 | 20168796 | 1.55 | 49.5 | Palliative (P) | 2018-06-28 | 2018-07-16 | Sorafenib | 02 | N | SORAFENIB | 100754645 |